| Filed On | Filing |
|---|---|
| 13 Feb 2026 |
Form 4/A: Bennett C Frank, EVP, Chief Scientific Officer
Disposed of 0 shares (Other Transaction) |
| 20 Jan 2026 |
Form 4/A: Kordasiewicz Holly B., EVP, Chief Development Officer
Granted 7,500 Non-Qualified Stock Option (right to buy) |
| 07 Nov 2025 |
Form 4/A: Geary Richard S, EVP, Chief Development Officer
Received 1,680 shares by exercise or conversion ($98.6K) · Sold 1,680 shares ($126K) |
| 04 Sep 2024 |
Form 4/A: Geary Richard S, EVP, Chief Development Officer
Sold 1,995 shares ($99.8K) |
| 04 Sep 2024 |
Form 4/A: Hougen Elizabeth L, EVP, Finance & CFO
Sold 2,162 shares ($107K) |
| 04 Sep 2024 |
Form 4/A: O'neil Patrick R., EVP CLO & General Counsel
Sold 1,995 shares ($99.1K) |
| 04 Sep 2024 |
Form 4/A: Schneider Eugene, EVP, Chf Clinical Develop Ofcr
Sold 2,106 shares ($104K) |
| 04 Sep 2024 |
Form 4/A: Swayze Eric, EVP Research
Sold 1,940 shares ($96.1K) |
| 04 Sep 2024 |
Form 4/A: Monia Brett P, Director
Sold 23,907 shares ($1.18M) |
| 04 Sep 2024 |
Form 4/A: Monia Brett P, Director
Sold 23,907 shares ($1.18M) |
| 04 Sep 2024 |
Form 4/A: Cadoret-Manier Onaiza, EVP,Chf GL Pdt Str & Oper Ofc
Sold 2,162 shares ($107K) |
| 04 Sep 2024 |
Form 4/A: Bennett C Frank, EVP, Chief Scientific Officer
Sold 1,885 shares ($93.3K) |
| 03 Jul 2024 |
Form 4/A: Yang Michael J., Director
Granted 4,079 Restricted Stock Unit |
| 17 Apr 2020 |
Form 4/A: Cadoret-Manier Onaiza, Chief Corp Dev and Cml Officer
Granted 22,667 Restricted Stock Unit |
| 27 Mar 2020 |
Form 4/A: Crooke Stanley T, Director
Sold 20,000 shares ($895K) |
| 31 Jan 2020 |
Form 4/A: Monia Brett P, Director
Granted 148,454 Employee Stock Option (right to buy) |
| 03 Jul 2019 |
Form 4/A: Castleman Breaux, Director
Received 1,333 shares by exercise or conversion · Granted 7,110 Restricted Stock Units · Granted 16,000 Director Stock Option (right to buy) · 2 more |
| 03 Jul 2019 |
Form 4/A: Berthelsen Spencer R, Director
Received 1,333 shares by exercise or conversion · Granted 7,110 Restricted Stock Units · Granted 16,000 Director Stock Option (right to buy) · 2 more |
| 03 Jul 2018 |
Form 4/A: Muto Frederick T, Director
Received 2,000 shares by exercise or conversion · Granted 3,555 Restricted Stock Units · Granted 16,000 Director Stock Option (right to buy) · 1 more |
| 05 Feb 2018 |
Form 4/A: Loscalzo Joseph, Director
Received 937 shares by exercise or conversion |
Loading...